In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
The art of software
Move over CAR-T: The potential of NK cells in cell therapy
Working for a mature form of genomic medicines
Challenges and opportunities in synthetic clinical trials
The commercialisation of quantum science in pharma
Conference report: Reuters Pharma Europe
In vitro gametogenesis: the science has to be right, and it has to be safe
Proving ROI for digital endpoints
Clinical trials: their design, location, and, potentially, their simulation
Pace, acceleration, and precision are the name of the game
Technology working as the puzzle piece to bring better outcomes to patients
Is precision psychiatry possible?
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape
Predictions for AI in mental health in the coming year
Fixing clinical trial data management
Harnessing the velocity of biopharmaceutical advances
Conference report: Reuters Pharma USA
The future of AI: Machine learning working together with scientific expertise
Understanding the politics of drug pricing in the United States
Female leadership and lessening disease burden
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Speaking of Psychology